Use of therapeutic plasma exchange in heparin-induced thrombocytopenia: A population-based study |
01/27/2021 - 4:00pm to 5:00pm EST |
Use of therapeutic plasma exchange as adjunctive therapy in the treatment of coronavirus disease |
02/24/2021 - 4:00pm to 5:00pm EST |
Use of plasma exchange for pediatric multi-inflammatory syndrome in children (MIS-C) |
12/22/2021 - 4:00pm to 5:00pm EST |
Therapeutic plasma exchange in patients with sepsis: Secondary analysis of a cluster-randomized controlled trial |
03/13/2024 - 3:30pm to 4:30pm EDT |
Therapeutic Options for Recurrence of FSGS in the Renal Allograft |
04/10/2024 - 3:30pm to 4:30pm EDT |
The ADAPT trial for myasthenia gravis |
05/31/2023 - 3:30pm to 4:03pm EDT |
Successful treatment of pure red cell aplasia using therapeutic plasma exchange after ABO-incompatible hematopoietic stem cell transplant |
02/22/2023 - 3:30pm to 4:30pm EST |
Stem cell mobilizating effect of heparin in patients undergoing autologous stem cell transplantation |
11/15/2023 - 3:30pm to 4:30pm EST |
Safety of Therapeutic Apheresis in Children and Adolescents |
08/10/2022 - 3:30pm to 4:30pm EDT |
Safety and Tolerability of Solvent/Detergent-Treated Plasma for Pediatric Patients Requiring Therapeutic Plasma Exchange |
10/19/2022 - 3:30pm to 4:30pm EDT |